Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen
ABSTRACTMiddle East respiratory syndrome coronavirus (MERS-CoV) is a lethal beta-coronavirus that emerged in 2012. The virus is part of the WHO blueprint priority list with a concerning fatality rate of 35%. Scientific efforts are ongoing for the development of vaccines, anti-viral and biotherapeuti...
Saved in:
Main Authors: | Rahul Ahuja (Author), Preeti Vishwakarma (Author), Sneha Raj (Author), Varun Kumar (Author), Ritika Khatri (Author), Bharat Lohiya (Author), Shikha Saxena (Author), Gurleen Kaur (Author), Gagandeep Singh (Author), Shailendra Asthana (Author), Shubbir Ahmed (Author), Sweety Samal (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficiently cleaved HIV-1 envelopes: can they be important for vaccine immunogen development?
by: Supratik Das, et al.
Published: (2020) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
by: Yoann Aldon, et al.
Published: (2021) -
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents
by: Pio Lopez, et al.
Published: (2023) -
A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
by: Ankit Gupta, et al.
Published: (2021) -
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
by: Yufei Wang, et al.
Published: (2017)